Skip to content
GLP-1 Scorecard
Menu
Graded #86

Science & Co

States in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two things almost nothing else here does.

Visit Science & CoWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$149/mo month-to-month ($79 only on a 12-month plan)
Tirzepatide
$199/mo month-to-month ($125 only on a 12-month plan)
Coverage
Not publicly listed
Brand-name
Compounded only

Weigh Science & Co against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Science & Co dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value74/100
Dose & formulation74/100
Clinical oversight76/100
Labs & monitoring55/100
Fulfillment80/100
Contract terms82/100

Strengths

  • States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
  • Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
  • The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
  • "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
  • Names its operating entity and state of incorporation, and says every batch is third-party tested

Where it loses points

  • The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
  • Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
  • It says it is not a compounding facility but never names the pharmacy that is
  • No lab or monitoring protocol is published
  • Injection only on the pages read — no oral route and no brand lane

Bottom line — Grade C

Best for: A twelve-month committer, or anyone who values a company saying plainly what it is and is not.

Ranked #86 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Science & Co — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Science & Co's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Science & Co's site. Not medical advice; see our disclosure.

← Back to the scorecard